OptimizeRx (OPRX) Research & Development (2025 - 2026)
OptimizeRx (OPRX) reported Research & Development of $3.4 million for Q1 2026, down 31.76% on a YoY basis from $5.0 million in Q1 2025, and down 31.76% sequentially from $5.0 million in Q1 2025.
OptimizeRx (OPRX) Research & Development (2025 - 2026) Analysis & Trends
OptimizeRx (OPRX) has 2 years of Research & Development data on file, last reported at $3.4 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | 26.83 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | 56.85 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | 30.34 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | 99.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | 45.83 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 39.11 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | 8.13 Mn |
| 10 | OptimizeRx | 127.35 Mn | 107.18 Mn | 14.93 Mn | 3.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.40 Mn |
| Mar 31, 2025 | 4.99 Mn |